VC-backed Lyra Therapeutics debuts IPO
Watertown, Massachusetts-based Lyra Therapeutics Inc, a developer of medicines to treat ear, nose and throat diseases, has raised $56 million for its IPO after pricing its 3.5 million shares at $16 per share.
Watertown, Massachusetts-based Lyra Therapeutics Inc, a developer of medicines to treat ear, nose and throat diseases, has raised $56 million for its IPO after pricing its 3.5 million shares at $16 per share.
Copyright PEI Media
Not for publication, email or dissemination